Loading organizations...
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Sep 1, 2017 | Rani Therapeutics | $39.0M Series D | — | Byers Capital, Founders' Co-op, Seven Seven Six, Susa Ventures, Y Combinator, Justin Mateen, AstraZeneca, Bossanova Investimentos, Cathay Innovation, Crystal Horizon Investments, Google Ventures, Novartis, Pacific Venture Opportunity Fund, Pinemount Investments |